Notice and Access Card



Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934 (Amendment No.
Filed by the Registrant   ☒           Filed by a Party other than the Registrant   ☐
Check the appropriate box:
☐ Preliminary Proxy Statement
Confidential, for use of the Commission Only (as Permitted by Rule 14A-6(e)(2))
☐ Definitive Proxy Statement
☒ Definitive Additional Materials

☐ Soliciting Material Pursuant to Section 240.14a-12

(Name of Registrant as Specified in its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
☒ No fee required
☐ Fee paid previously with preliminary materials.

☐ Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.

Your Vote Counts! CLOVER HEALTH INVESTMENTS, CORP. 3401 MALLORY LANE SUITE 210 FRANKLIN, TN 37067 ATTN: CORPORATE SECRETARY CLOVER HEALTH INVESTMENTS, CORP. 2023 Annual Meeting Vote by June 6, 2023 11:59 PM ET You invested in CLOVER HEALTH INVESTMENTS, CORP. and it’s time to vote! You have the right to vote on proposals being presented at the Annual Meeting. This is an important notice regarding the availability of proxy material for the stockholder meeting to be held on June 7, 2023. Vote Virtually at the Meeting* June 7, 2023 11:00 a.m., Eastern Time Virtually at: *Please check the meeting materials for any special requirements for meeting attendance. Smartphone users Point your camera here and vote without entering a control number For complete information and to vote, visit Control # V13362-P88040 Get informed before you vote View the Annual Report and Notice & Proxy Statement online OR you can receive a free paper or email copy of the material(s) by requesting prior to May 24, 2023. If you would like to request a copy of the material(s) for this and/or future stockholder meetings, you may (1) visit, (2) call 1-800-579-1639 or (3) send an email to If sending an email, please include your control number (indicated below) in the subject line. Unless requested, you will not otherwise receive a paper or email copy. V1.2

THIS IS NOT A VOTABLE BALLOT This is an overview of the proposals being presented at the upcoming stockholder meeting. Please follow the instructions on the reverse side to vote these important matters. Vote at Prefer to receive an email instead? While voting on, be sure to click “Delivery Settings”. Voting Items Board Recommends V13363-P88040 01) Demetrios L. Kouzoukas 02) Andrew Toy 1. Election of Directors Nominees: 2. Non-binding advisory proposal to approve the compensation paid to our named executive officers for 2022. 3. The ratification of the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm. In their discretion, to vote or act upon such other matters that may properly come before the meeting or any adjournment or adjournments thereof. For For For